Evaluation of GLP-2 receptor expression in gastrointestinal neuroendocrine tumors

Authors : Şule NAMLI KOÇ, Özgül SAĞOL, Mesut AKARSU

Pages : 52-58

Doi:10.17941/agd.1349571

View : 17 | Download : 20

Publication Date : 2023-08-31

Article Type : Research Paper

Abstract :Evaluation of GLP-2 receptor expression in gastrointestinal neuroendocrine tumors Background and Aims: Neuroendocrine tumors arise from cells of the neuroendocrine system. These cells show both nerve and endocrine cell characteristics and can be found in many organs in the body. GLP-1 and GLP-2 are released from intestinal L cells in a 1:1 ratio following food intake. GLP-2 receptor recognizes GLP-2. GLP-2 receptor mRNA transcripts have been detected in the stomach, small and large intestine, brain, and lung. The proliferative effect of GLP-2 has been demonstrated in mice, rats, pigs, and humans by administering exogenous GLP-2. The objective is to evalaute the relation between gastroenteropancreatic neuroendocrine tumors and glukagon like peptid-2 and GLP-2 receptor. Materials and Methods: The patients, who were pathologically diagnosed with gastroenteropancreatic neuroendocrine tumor between 2006-2009 were included in the study. There were 47 patients insert ignore into journalissuearticles values(27 females, 20 males, avarage age: 54 ± 15.5); in the study. There were also 46 control group patients insert ignore into journalissuearticles values(25 females, 21 males, avarage age: 57.5 ± 14.8);. Pathological tissue blocks prepared on poly-L-lysine microscope slides were stained by GLP-2 receptor antibody insert ignore into journalissuearticles values(1:100 - 1:200, 1 mg/ml); immunohistochemical stain. Results: GLP-2 receptor positivity of colon neuroendocrine tumor group was 30% insert ignore into journalissuearticles values(4/13); and colon control group was %100. GLP-2 receptor positivity of pancreas neuroendocrine tumor group was 25% insert ignore into journalissuearticles values(3/12); while it was 100% in pancreas control group. The comparison of colon neuroendocrine tumor and control group showed significant difference insert ignore into journalissuearticles values(p: 0.003);. The comparison of pancreas neuroendocrine tumor and control group also showed statistically significant difference insert ignore into journalissuearticles values(p < 0.001);. The comparison of gastric neuroendocrine tumor with the control yielded comparable results insert ignore into journalissuearticles values(p: 0.22);. Conclusions: We concluded that GLP-2 receptor cannot be as useful as somatostatin receptors in diagnosis and treatment of these tumors. More studies are needed on this subject with different methods.
Keywords : GLP 2 reseptörü, nöroendokrin tümörler, GEP NET